HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$9.27
Day range
$9.02 - $9.40
Year range
$2.82 - $9.40
Market cap
1.48B USD
Avg Volume
2.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 71.54M | 48.84% |
Operating expense | 55.16M | 13.82% |
Net income | -1.93M | 87.15% |
Net profit margin | -2.69 | 91.38% |
Earnings per share | -0.01 | 90.00% |
EBITDA | 7.52M | 244.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.28M | -23.57% |
Total assets | 334.69M | 0.89% |
Total liabilities | 353.99M | 0.85% |
Total equity | -19.30M | — |
Shares outstanding | 161.48M | — |
Price to book | -77.25 | — |
Return on assets | 3.45% | — |
Return on capital | 4.75% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.93M | 87.15% |
Cash from operations | 182.00K | 101.76% |
Cash from investing | -279.00K | -106.06% |
Cash from financing | 942.00K | 42.94% |
Net change in cash | 845.00K | 116.61% |
Free cash flow | -2.30M | 68.94% |
About
Founded
2005
Headquarters
Website
Employees
394
